Out of 4 analysts covering Aviva (NYSE:AV), 3 rate it “Buy”, 1 “Sell”, while 0 “Hold”. This means 75% are positive. Aviva was the topic in 4 analyst reports since September 24, 2015 according to StockzIntelligence Inc. Below is a list of Aviva Plc (ADR) (NYSE:AV) latest ratings and price target changes.
27/11/2015 Broker: RBC Capital Markets Old Rating: Sector Perform New Rating: Underperform Downgrade
16/11/2015 Broker: Bank of America Old Rating: Neutral New Rating: Buy Upgrade
30/10/2015 Broker: Beaufort Securities Rating: Buy Upgrade
24/09/2015 Broker: Goldman Sachs Rating: Buy Reinitiate
About 78,829 shares traded hands. Aviva Plc (ADR) (NYSE:AV) has declined 15.90% since August 7, 2015 and is downtrending. It has underperformed by 13.11% the S&P500.
Aviva plc is a provider of long-term insurance and savings general and health insurance and fund management services and products. The company has a market cap of $27.96 billion. The Firm operates across four lines of business: The Company’s long-term insurance and savings business, which includes a range of life insurance and savings products; general insurance, which focuses on personal and commercial lines, health insurance and fund management, which manages funds on behalf of its long-term insurance and general insurance businesses, external institutions, pension funds and retail clients. It currently has negative earnings.
The institutional sentiment increased to 2.19 in Q3 2015. Its up 0.43, from 1.76 in 2015Q2. The ratio improved, as 8 funds sold all Aviva Plc (ADR) shares owned while 18 reduced positions. 12 funds bought stakes while 45 increased positions. They now own 17.78 million shares or 15.20% more from 15.43 million shares in 2015Q2.
Wright Investors Service Inc holds 1.54% of its portfolio in Aviva Plc (ADR) for 247,752 shares. Causeway Capital Management Llc owns 1.75 million shares or 0.48% of their US portfolio. Moreover, Thornburg Investment Management Inc has 0.31% invested in the company for 3.60 million shares. The Virginia-based Yorktown Management & Research Co Inc has invested 0.25% in the stock. Euclid Advisors Llc, a Connecticut-based fund reported 370,917 shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.